India's Supreme Court rejects a plea by Novartis to patent an updated version of its cancer drug, Glivec (Imatinib), amid concerns that a patent could threaten access to cheap generic versions of drugs in poorer countries. (BBC) (The Guardian) (The Washington Post) (The New York Times)